Bambusa Vulgaris Extract · 5% aqueous hydroglycerin stock
Formulate Labs offers Bambusa Vulgaris Extract, a fixed 5% hydroglycerin stock harnessing the power of over 70% organic silica and potent flavonoids like orientin and vitexin. This INCI-standardized active is distinct from general bamboo powders or silica sources, providing a clear, high-performance solution for advanced cosmetic formulations.
Supports skin's natural resilience.
Bambusa Vulgaris Extract, derived from the resilient bamboo plant, is a sophisticated botanical active specifically engineered for high bioavailability and efficacy in cosmetic formulations. Unlike generic forms such as Bambusa vulgaris stem/leaf powder, bamboo silica, or simply bamboo stem, our offering is standardized as the INCI Bambusa Vulgaris Extract, ensuring consistent quality and performance for formulators focused on precise ingredient specifications rather than broad supplier SKUs.
Dual mechanism: Bambusa Vulgaris Extract's cosmetic action is driven by its rich composition of over 70% organic silica and potent flavonoids, including orientin and vitexin. First, the bioavailable silica provides structural support to the skin's architecture by reinforcing the extracellular matrix, helping to maintain the stability of crucial proteins like collagen and elastin, thereby supporting skin's structural resilience and enhancing barrier hydration. Second, the extract's flavonoid complex delivers sophisticated antioxidant and soothing benefits, neutralizing damaging reactive oxygen species (ROS) to help protect the skin from visible signs of environmental stressors and UVB-induced photoaging, while also helping to mitigate inflammatory signaling pathways for calming compromised or reactive skin.
Use levels: Formulate Labs' 5% hydroglycerin stock of Bambusa Vulgaris Extract is typically incorporated into cosmetic formulations at a rate of 0.25% to 5.0% of the final product. For optimal efficacy, a 2.0% use level of this stock is recommended, with minimal bio-activity observed below 0.1%.
Market context: Formulate Labs’ Bambusa Vulgaris Extract is positioned as a premium, science-backed active, differentiating itself from competitors by emphasizing a high-tech, dual-action mechanism. While some market offerings like 'HYDRALPHATINE™ ASIA-class actives' focus on sustainable hydration, and 'Bamboo Extract PB-class actives' target calming properties, Formulate Labs highlights the high concentration of bioavailable silica for reinforcing skin's foundational matrix and potent flavonoids for sophisticated antioxidant and soothing benefits, providing a comprehensive solution for resilient, healthy-looking skin.
Pricing context: Public B2B pricing data for high-purity, liquid suspensions of Bambusa Vulgaris Extract is limited, with available intelligence primarily for standardized botanical powder extracts ranging from $100 to $900 per kilogram. Formulate Labs' high-bioavailability liquid extract is competitively priced: a 500g sample for $295.00, 1kg for $450.00, and a 17kg pail for $6,502.50, equating to $382.50 per kilogram.
We ship a fixed 5% extract blend with selectable preservation - ready to meter into water-phase formulas at the use rates in the formulation guide below.*
Note: Common trade names like (Bambusa vulgaris stem/leaf powder, bamboo silica, bamboo stem) refer to forms of bamboo material, while Bambusa Vulgaris Extract is the specified INCI name for this cosmetic raw material.
Every lot is produced to order in our AI-powered robotic factory. Nothing sits on a warehouse shelf going stale - you get a date-of-manufacture-fresh batch every time.
* Structure/function statements based on published cosmetic in-vitro studies. Not evaluated for, and not intended to, diagnose, treat, cure, or prevent any disease.
Extensive peer-reviewed research supports the cosmetic efficacy of Bambusa Vulgaris Extract across multiple skin concerns. Studies highlight its ability to influence melanin production, reduce sebum output, improve the appearance of acneic lesions, and support the skin's natural repair processes by enhancing fibroblast proliferation and collagen synthesis. These are independent, third-party papers we link for formulators evaluating mechanism, tolerability, and published panel data. We did not conduct this research and do not guarantee replication in your finished formula.
Demonstrates the extract's influence on melanin production pathways, supporting its use in formulations designed to promote a brighter, more even-looking skin tone and address the appearance of hyperpigmentation.
Clinical findings show a significant reduction in sebum output and an improved appearance of acneic lesions, validating the extract's use in clarifying products for oily and blemish-prone skin.
Validates the extract’s ability to support the skin's natural repair processes by enhancing fibroblast proliferation and collagen synthesis, making it a compelling ingredient for restorative skin care products.
These citations are provided for informational and formulation-research purposes only. Study designs, concentrations, vehicle systems, and populations vary and may not match the hydroglycerin stocks on this page. Published results do not constitute FDA or EU cosmetic claim substantiation for your brand. Always review the primary literature and consult your regulatory counsel before making structure/function statements on finished products.
Bulk composition at fixed 5% Bambusa Vulgaris Extract loading. Base carrier components scale proportionally when preservative is added; extract stays at 5%. Updates dynamically when you change base or preservation above. Full CAS disclosure is on the SDS/TDS for the selected variant (FL-BAV-W2-MBS4-5PCT-001).
SDS + TDS are issued per base and preservative combination. Links swap when you change selections above. COA is batch-specific and ships with the order.
Statements contained on this page (including any marked with *) have not been evaluated by the U.S. Food and Drug Administration. This product is a cosmetic raw material and is not intended to diagnose, treat, cure, or prevent any disease.
